Advertisement

CardioVasc

, Volume 19, Issue 1, pp 27–29 | Cite as

Pro und Kontra

Absenkung der Zielblutdruckwerte im Alter

  • Timm H. WesthoffEmail author
Fortbildung Schwerpunkt Hypertonie

Dass der Blutdruck auch bei Älteren und Hochbetagten eingestellt werden soll, steht außer Frage. Die Hypertonie unbehandelt zu lassen ist keine Option. Auf welche Werte die Einstellung erfolgen soll, ist allerdings einer Diskussion würdig und wird unterschiedlich gesehen. Lesen Sie eine ausführliche Erörterung des Themas durch zwei Experten.

Literatur

  1. 1.
    Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219CrossRefGoogle Scholar
  2. 2.
    James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20CrossRefGoogle Scholar
  3. 3.
    Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269–324CrossRefGoogle Scholar
  4. 4.
    Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041CrossRefGoogle Scholar
  5. 5.
    Beckett NS, Peters R, Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–98CrossRefGoogle Scholar
  6. 6.
    Group SR, Wright JT, Jr., Williamson JD et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103–16CrossRefGoogle Scholar
  7. 7.
    Williamson JD, Supiano MA, Applegate WB et al. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged.75 Years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673–82CrossRefGoogle Scholar
  8. 8.
    Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014(3):CD000029.Google Scholar
  9. 9.
    Messerli FH, Mancia G, Conti CR et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884–93CrossRefGoogle Scholar
  10. 10.
    McEvoy JW, Chen Y, Rawlings A et al. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control. J Am Coll Cardiol. 2016;68(16):1713–22CrossRefGoogle Scholar
  11. 11.
    Filipovsky J, Seidlerova J, Kratochvil Z et al. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25(4):228–34CrossRefGoogle Scholar
  12. 12.
    Cheung AK, Rahman M, Reboussin DM et al. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017;28(9):2812–23CrossRefGoogle Scholar
  13. 13.
    Hajjar I, Rosenberger KJ, Kulshreshtha A et al. Association of JNC-8 and SPRINT Systolic Blood Pressure Levels With Cognitive Function and Related Racial Disparity. JAMA Neurol. 2017;74(10):1199–205CrossRefGoogle Scholar
  14. 14.
    Johnson KC, Whelton PK, Cushman WC et al. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018;71(5):848–57CrossRefGoogle Scholar
  15. 15.
    Bauer F, Seibert FS, Rohn B, Bauer KAR, Rolshoven E, Babel N, et al. Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting. Hypertension. 2018;71(2):243–9CrossRefGoogle Scholar
  16. 16.
    Bohm M, Schumacher H, Teo KK et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389(10085):2226–37CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Medizinische Klinik IUniversitätsklinikum der Ruhr-Universität Bochum Marien Hospital HerneHerneDeutschland

Personalised recommendations